This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Mallinckrodt Acquires Questcor for $5.6B

Stocks in this article: QCOR

NEW YORK (The Deal) -- Dublin, Ireland-based Mallinckrodt Pharmaceuticals has broadened its strategic product growth platform with the $5.6 billion acquisition of Questcor Pharmaceuticals (QCOR).

Questcor's major product is Acthar gel, a depot injectable corticosteroid approved by the Food and Drug Administration for 19 conditions, mostly autoimmune and inflammatory. Mallinckrodt executives say they plan to expand the market for Acthar internationally.

Questcor's net sales grew 57%, to $799 million, in 2013.

Anaheim, Calif.-based Questcor shareholders will receive $30 in cash and 0.897 Mallinckrodt shares for each share of Questcor common stock they own.

The parties expect the deal to close in the third calendar quarter this year, although it is contingent on shareholder acceptance and regulatory approvals. Former Questcor shareholders would own 49.5% of the merged company.

Mallinckrodt, which has been exceptionally active in M&A over the past year, says this deal is its "high-water market" for the time being. However, it will continue to look at smaller acquisitions of companies and products that would help it meet its goal of becoming a top-tier specialty pharmaceuticals company.

"We wouldn't rule out any type of transaction," Matthew Harbaugh, Mallinckrodt chief financial officer, said in a conference call with investors Monday, April 7.

Mallinckrodt says its business is characterized by creating and selling difficult-to manufacture, complex and highly specialized drugs. It is focused on markets in the rheumatology, nephrology, pulmonology and other therapeutic spaces.

Mallinckrodt will remain domiciled in Ireland. It expects that Questcor business will gain an immediate benefit of about 10% decline in tax rate due to Ireland's significantly lower business taxes.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs